Noninvasive transdermal delivery of peptides and proteins

Drugs of the Future

Volumn 26, Issue 8, 2001, Pages 779-791

  Pillai, O ^a   Nair, V ^a   Jain, A K ^a   Thomas, N S ^a   Panchagnula, R ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ARGININE; ARGIPRESSIN[DEGLYCINAMIDE]; BUSERELIN; CALCITONIN; CHOLECYSTOKININ DERIVATIVE; DELTA SLEEP INDUCING PEPTIDE; DESMOPRESSIN; ENKEPHALIN; GONADORELIN; GONADOTROPIN; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; INSULIN; INTERMEDIN; LEUPRORELIN; NAFARELIN; OCTREOTIDE; PARATHYROID HORMONE; RO 23786; UNCLASSIFIED DRUG; VASOPRESSIN;

BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; ELECTROPORATION; IONTOPHORESIS; POWDER; PROTEIN TRANSPORT; REVIEW;

EID: 0034777711     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.08.858714     Document Type: Review

References (102)

1. Drug Discovery: A historical perspective
2. Quo vadis, biotech? (Part I)
3. Transdermal drug delivery: Overcoming the skin's barrier function
4. The skin as a drug metabolizing enzyme
5. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
6. Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications
7. Transdermal delivery of peptides and proteins
8. Iontophoresis in drug delivery: Basic principles and applications
9. Iontophoretic delivery of peptide drugs
10. Percutaneous delivery of proteins and peptides using iontophoretic techniques
11. Transdermal iontophoresis. Part I: Basic principles and considerations
12. Transdermal iontophoresis. Part II: Peptide and protein delivery
13. What are the pathways of iontophoretic current flow through mammalian skin?
14. Sites of iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode
15. Visualization and analysis of etectroosmotic flow in hairless mouse skin
16. Characterization of the permselective properties of skin
17. Penetration enhancement of peptide and protein drugs by electrochemical means: Transdermal iontophoresis
18. Transdermal iontophoresis revisited
19. Iontophoresis: Electrorepulsion and electroosmosis
20. The role of electroosmotic flow of transdermal iontophoresis
21. Mechanistic aspects of iontophoresis in human epidermal membrane
22. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration and electroosmosis to transport in hair follicles
23. Characterization of convective solvent flow during iontophoresis
24. Transdermal iontophoresis: Modulation of electroosmosis by polypeptides
25. Iontophoretic permeability of polyethylene glycols through hairless rat skin: Application of hydrodynamic theory for hindered transport through liquid-filled pores
26. Epidermal iontophoresis I. Development of the ionic mobility-pore model
27. Analysis of skin permeation-enhancing mechanism of iontophoresis using hydrodynamic pore theory
28. Characterization of the iontophoretic properties of human and pig skin
29. Iontophoresis of monomeric insulin analogues in vitro: Effects of insulin charge and skin pretreatment
30. Transdermal iontophoretic delivery of thyrotropin releasing hormone across rabbit pinna skin
31. Electrotransport systems for transdermal delivery: A practical implementation of iontophoresis
32. Transdermal iontophoretic delivery of insulin using a photoetched microdevice
33. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery
34. A practical assessment of transdermal drug delivery by skin electroporation
35. In vivo efficacy and safety of skin electroporation
36. Transdermal permeation of neutral molecules by skin electroporation
37. Transdermal delivery of fentanyl by electroporation I: Influence of electric factors
38. Rapid temporal control of transdermal drug delivery by electroporation
39. Effects of iontophoresis and electroporation on the SC: Review of the biophysical studies
40. Transdermal alnitidan delivery by skin electroporation
41. Transdermal delivery of flurbiprofen in the rat by iontophoresis and electroporation
42. Skin electroporation: Rapid measurements of the transdermal voltage and flux of four fluorescent molecules show a transition to large fluxes near 50 V
43. Effect of electroporation on transdermal iontophoretic delivery of LHRH in vitro
44. Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology
45. Transdermal delivery of cyclosporin-A using electroporation
46. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones
47. Transport of DNA antisense oligonucleotide across human skin by electroporation
48. Transdermal delivery of heparin by skin electroporation
49. Transdermal drug delivery using electroporation I: Factors influencing in vitro delivery of terazosin hydrochloride in hairless pig
50. Transdermal delivery of fentanyl: Rapid onset of analgesia using skin electroporation
51. Transdermal drug delivery using electroporation II: Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats
52. In vivo noninvasive evaluation of hairless rat skin after high voltage pulse exposure
53. Methods for in vivo tissue electroporation using surface electrodes
54. Frequency dependence of acoustic cavitation
55. Determination of threshold energy dose for ultrasound-induced transdermal drug transport
56. A mechanistic study of ultrasonically enhanced transdermal drug delivery
57. Effect of ultrasound application on skin metabolism of prednisolone 21-acetate
58. Free radical formation induced by ultrasound and its biological implications
59. Ultrasound-mediated transdermal protein delivery
60. Transdermal delivery of insulin by ultrasonic vibration
61. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasonic exposure
62. Transdermal drug delivery using low-frequency sonophoresis
63. Sonophoresis II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery
64. Synergistic effect of enhancers for transdermal drug delivery
65. Transdermal iontophoretic drug delivery: Mechanistic analysis and application to polypeptide delivery
66. A comparative evaluation of the effect of penetration enhancers on passive diffusion and iontophoretic transport of insulin
67. Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly-devised switching technique and addition of urea
68. Transdermal delivery of regular insulin to chronic diabetic rats: Effect of skin preparation and electrical enhancement
69. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis
70. Transdermal iontophoresis of insulin: Effect of penetration enhancers on blood glucose level in diabetic rats
71. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue
72. Iontophoresis of polypeptides: Effect of ethanol pretreatment of human skin
73. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin
74. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin
75. Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: Permeability and lipid extraction studies
76. Lipid extraction and iontophoretic transport of leuprolide acetate through porcine epidermis
77. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin
78. Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum
79. Transdermal macromolecular delivery: Real-time visualization of iontophoretic and chemically enhanced transport using two photon excitation microscopy
80. Macromolecules as novel transdermal transport enhancers for skin electroporation
81. Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits
82. Synergistic effect of ultrasound and iontophoresis on transdermal drug delivery: Applications to heparin delivery
83. Synergistic effect of ultrasound and sodium lauryl sulfate on transdermal drug delivery
84. Enhanced transdermal delivery: Synergistic effect of ultrasound and electroporation
85. Transdermal delivery of powdered bovine insulin to diabetic and non-diabetic Wistar rats
86. Transdermal and transmucosal powdered drug delivery
87. Transdermal powdered delivery (TPD): In vivo determination of particle penetration depth and therpaeutic efficacy
88. Administration of insulin via dermal PowderJect®: Reproducible and dose-dependent delivery to the anaesthetized rat
89. Dermal and transdermal delivery of protein pharmaceuticals: Lipid-based delivery systems for interferon α
90. Topical delivery of liposomally encapsulated γ-interferon
91. Transdermal iontophoretic delivery of enkephalin formulated in liposomes
92. Transferosomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery
93. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force
94. Transdermal immunization with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transferosomes